Champix Tagged Articles

Chantix significantly increases cardiovascular risks, according to another new study

Posted: July 8, 2011 Pharmaceutical

Last month, the Food and Drug Administration warned of newly discovered cardiovascular risks associated with Pfizer’s popular smoking-cessation drug Chantix. But it turns out those risks, which include higher occurrence of heart attack and other adverse cardiovascular events in Chantix

Health Canada issues stronger warnings about Champix,Chantix

Posted: June 9, 2010 Pharmaceutical

Health Canada has ordered Pfizer Canada to issue stronger warnings about its smoking cessation medication Champix, also known as Chantix in the United States, because of numerous reports of serious neuropsychiatric symptoms and some cases of the potentially fatal skin

FDA now requiring stronger warnings on Chantix labels

Posted: July 1, 2009 Pharmaceutical

The U.S. Food and Drug Administration announced today that it will require drug manufacturers to put boxed warnings on the product labeling for Chantix (varenicline) and Zyban (bupropion hydrochloride, otherwise called Wellbutrin when prescribed as an antidepressant). Both Chantix and

More Canadians harmed by Chantix as government revises warnings

Posted: February 10, 2009 Pharmaceutical

Health Canada has received 818 reports of adverse side effects caused by the smoking cessation drug Chantix (marketed in Canada and elsewhere as Champix) since it first became available to Canadians nearly two years ago. The majority of complaints concerned

Canada strengthens Chantix warnings

Posted: January 20, 2009 Pharmaceutical

The Canadian Press reports that Health Canada, the government department responsible for Canada’s public health policies, is currently working with Pfizer to strengthen the warnings for the smoking cessation drug Chantix. Chantix is sold in Canada and elsewhere overseas under

BBC investigates Chantix suicides in the UK

Posted: December 1, 2008 Pharmaceutical

An investigative report aired by the British Broadcasting Company (BBC) tells the stories of two people who became suicidal after taking Chantix (marketed by Pfizer as Champix in Europe and the UK). Chantix became available in the UK in December